186 related articles for article (PubMed ID: 16675931)
21. Identification of novel pathogenic variants and features in patients with pseudohypoparathyroidism and acrodysostosis, subtypes of the newly classified inactivating PTH/PTHrP signaling disorders.
Truelove A; Mulay A; Prapa M; Casey RT; Adler AI; Offiah AC; Poole KES; Trotman J; Al Hasso N; Park SM
Am J Med Genet A; 2019 Jul; 179(7):1330-1337. PubMed ID: 31041856
[TBL] [Abstract][Full Text] [Related]
22. Resistance to GHRH but Not to PTH in a 15-Year-Old Boy With Pseudohypoparathyroidism 1A.
Munteanu M; Kiewert C; Matar N; Hauffa BP; Unger N; Hiort O; Thiele S; Buiting K; Bramswig NC; Grasemann C
J Endocr Soc; 2019 Jul; 3(7):1383-1389. PubMed ID: 31286103
[TBL] [Abstract][Full Text] [Related]
23. Cognitive impairment is prevalent in pseudohypoparathyroidism type Ia, but not in pseudopseudohypoparathyroidism: possible cerebral imprinting of Gsalpha.
Mouallem M; Shaharabany M; Weintrob N; Shalitin S; Nagelberg N; Shapira H; Zadik Z; Farfel Z
Clin Endocrinol (Oxf); 2008 Feb; 68(2):233-9. PubMed ID: 17803690
[TBL] [Abstract][Full Text] [Related]
24. GNAS epigenetic defects and pseudohypoparathyroidism: time for a new classification?
Mantovani G; Elli FM; Spada A
Horm Metab Res; 2012 Sep; 44(10):716-23. PubMed ID: 22674477
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of Chiari malformation type 1 is increased in pseudohypoparathyroidism type 1A and associated with aberrant bone development.
Krishnan N; McMullan P; Yang Q; Buscarello AN; Germain-Lee EL
PLoS One; 2023; 18(1):e0280463. PubMed ID: 36662765
[TBL] [Abstract][Full Text] [Related]
26. Tertiary hyperparathyroidism in patients with pseudohypoparathyroidism type 1a.
Itoh M; Okajima M; Kittaka Y; Yachie A; Wada T; Saikawa Y
Bone Rep; 2022 Jun; 16():101569. PubMed ID: 35497370
[TBL] [Abstract][Full Text] [Related]
27. Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Galpha(s) in the development of human obesity.
Long DN; McGuire S; Levine MA; Weinstein LS; Germain-Lee EL
J Clin Endocrinol Metab; 2007 Mar; 92(3):1073-9. PubMed ID: 17164301
[TBL] [Abstract][Full Text] [Related]
28. The stimulatory G protein alpha-subunit Gs alpha is imprinted in human thyroid glands: implications for thyroid function in pseudohypoparathyroidism types 1A and 1B.
Liu J; Erlichman B; Weinstein LS
J Clin Endocrinol Metab; 2003 Sep; 88(9):4336-41. PubMed ID: 12970307
[TBL] [Abstract][Full Text] [Related]
29. Progressive osseous heteroplasia, as an isolated entity or overlapping with Albright hereditary osteodystrophy.
Lin MH; Numbenjapon N; Germain-Lee EL; Pitukcheewanont P
J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):911-8. PubMed ID: 25894639
[TBL] [Abstract][Full Text] [Related]
30. A pseudohypoparathyroidism type Ia patient with normocalcemia.
Tamada Y; Kanda S; Suzuki H; Tajima T; Nishiyama T
Endocr J; 2008 Mar; 55(1):169-73. PubMed ID: 18250541
[TBL] [Abstract][Full Text] [Related]
31. Evidence of hormone resistance in a pseudo-pseudohypoparathyroidism patient with a novel paternal mutation in GNAS.
Turan S; Thiele S; Tafaj O; Brix B; Atay Z; Abali S; Haliloglu B; Bereket A; Bastepe M
Bone; 2015 Feb; 71():53-7. PubMed ID: 25464124
[TBL] [Abstract][Full Text] [Related]
32. Albright's hereditary osteodystrophy and pseudohypoparathyroidism.
Wilson LC; Hall CM
Semin Musculoskelet Radiol; 2002 Dec; 6(4):273-83. PubMed ID: 12541184
[TBL] [Abstract][Full Text] [Related]
33. A novel mutation causing pseudohypoparathyroidism 1A with congenital hypothyroidism and osteoma cutis.
Lubell T; Garzon M; Anyane Yeboa K; Shah B
J Clin Res Pediatr Endocrinol; 2009; 1(5):244-7. PubMed ID: 21274302
[TBL] [Abstract][Full Text] [Related]
34. Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients.
Mantovani G; de Sanctis L; Barbieri AM; Elli FM; Bollati V; Vaira V; Labarile P; Bondioni S; Peverelli E; Lania AG; Beck-Peccoz P; Spada A
J Clin Endocrinol Metab; 2010 Feb; 95(2):651-8. PubMed ID: 20061437
[TBL] [Abstract][Full Text] [Related]
35. Follow-up Findings in a Turkish Girl with Pseudohypoparathyroidism Type Ia Caused by a Novel Heterozygous Mutation in the GNAS Gene.
Şahin S; Hiort O; Thiele S; Evliyaoğlu O; Tüysüz B
J Clin Res Pediatr Endocrinol; 2017 Mar; 9(1):74-79. PubMed ID: 27425121
[TBL] [Abstract][Full Text] [Related]
36. Pseudohypoparathyroidism type Ib in 2015.
Mantovani G; Elli FM
Ann Endocrinol (Paris); 2015 May; 76(2):101-4. PubMed ID: 25910998
[TBL] [Abstract][Full Text] [Related]
37. Genetic basis for resistance to parathyroid hormone.
Levine MA; Germain-Lee E; Jan de Beur S
Horm Res; 2003; 60 Suppl 3():87-95. PubMed ID: 14671404
[TBL] [Abstract][Full Text] [Related]
38. Recent advances in GNAS epigenetic research of pseudohypoparathyroidism.
Izzi B; Van Geet C; Freson K
Curr Mol Med; 2012 Jun; 12(5):566-73. PubMed ID: 22300135
[TBL] [Abstract][Full Text] [Related]
39. Minireview: GNAS: normal and abnormal functions.
Weinstein LS; Liu J; Sakamoto A; Xie T; Chen M
Endocrinology; 2004 Dec; 145(12):5459-64. PubMed ID: 15331575
[TBL] [Abstract][Full Text] [Related]
40. Progressive osseous heteroplasia-like heterotopic ossification in a male infant with pseudohypoparathyroidism type Ia: a case report.
Gelfand IM; Hub RS; Shore EM; Kaplan FS; Dimeglio LA
Bone; 2007 May; 40(5):1425-8. PubMed ID: 17321228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
